为患有胆囊癌的患者提供个性化的护理
Laura M Nicolais1, Timothy L Fitzgerald2
1Division of Surgical Oncology, Tufts University School of Medicine-Maine Medical Center, 22 Bramhall St., Portland, ME, 04102, USA; Tufts University Clinical and Translational Science Graduate Program, Graduate School of Biomedical Sciences, 35 Kneeland St., Boston, MA, 02111, USA.
除了胆囊切除外的手术可以改善胆囊癌患者在所有阶段的生存率. 辅助化疗对III/IVA阶段有利,而化疗对II阶段及以上阶段有利,有助于治疗决策.
科学领域:
- 手术瘤学手术瘤学
- 胃肠道瘤学 胃肠道瘤学
- 临床证据 临床证据
背景情况:
- 胆囊癌是罕见的,只有有限的高水平证据指导患者护理.
- 可切除胆囊腺癌的最佳治疗策略仍在研究中.
研究的目的:
- 评估胆囊腺癌不同治疗方式的生存益处.
- 确定预后因素,并为患者的结果开发预测工具.
主要方法:
- 国家癌症数据库 (NCDB) 队列研究包括8484名从2004年至2018年切除胆囊腺癌 (IB-IVA阶段) 的患者.
- 进行了生存分析,比较单独胆囊切除术的结果与胆囊切除术后的手术,以及辅助疗法的影响.
主要成果:
- 平均存活时间为29.8个月. 除了胆囊切除外的手术显著改善了所有研究阶段 (IB,II,III/IVA) 的生存率.
- 化学辐射疗法在II和III阶段/IVA疾病中显示出生存益处. 辅助化疗在III阶段/IVA阶段改善了生存率,但在IB阶段没有益处,而且趋向于危害.
- 基于这些发现,开发了一种预测性名ogram.
结论:
- 除了简单的胆囊切除外,手术切除对胆囊腺癌的所有阶段都提供了生存优势.
- 辅助化疗对第三阶段/IVA疾病有益,化学辐射疗法对第二阶段和更高阶段有益,指导晚期胆囊癌的治疗选择.
更多相关视频
13:56Robot Assisted Distal Pancreatectomy with Celiac Axis Resection DP-CAR for Pancreatic Cancer: Surgical Planning and Technique
Published on: August 14, 2021
09:49Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization
Published on: December 2, 2013
相关概念视频
Chronic Pancreatitis II: Collaborative Care
Assessment:
Nursing Ethical Principles II
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Gallbladder
The gallbladder's anatomy consists of three regions: the fundus, body, and neck. Extending from the neck, the cystic duct joins...
Acute Pancreatitis II: Clinical Manifestations and Management
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
